Citadel Advisors’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-81,204
| Closed | -$756K | – | 6218 |
|
|
2024
Q3 | $756K | Buy |
81,204
+16,354
| +25% | +$152K | ﹤0.01% | 3369 |
|
|
2024
Q2 | $373K | Buy |
64,850
+40,877
| +171% | +$235K | ﹤0.01% | 4089 |
|
|
2024
Q1 | $161K | Buy |
+23,973
| New | +$161K | ﹤0.01% | 4885 |
|
|
2023
Q2 | – | Sell |
-153,072
| Closed | -$949K | – | 5995 |
|
|
2023
Q1 | $949K | Buy |
153,072
+89,291
| +140% | +$554K | ﹤0.01% | 3226 |
|
|
2022
Q4 | $407K | Sell |
63,781
-3,911
| -6% | -$25K | ﹤0.01% | 4052 |
|
|
2022
Q3 | $581K | Buy |
+67,692
| New | +$581K | ﹤0.01% | 3938 |
|
|
2022
Q2 | – | Sell |
-58,546
| Closed | -$892K | – | 6283 |
|
|
2022
Q1 | $892K | Buy |
+58,546
| New | +$892K | ﹤0.01% | 3856 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6669 |
|